TY - JOUR
T1 - Structures, functions and adaptations of the human LINE-1 ORF2 protein
AU - Baldwin, Eric T.
AU - van Eeuwen, Trevor
AU - Hoyos, David
AU - Zalevsky, Arthur
AU - Tchesnokov, Egor P.
AU - Sánchez, Roberto
AU - Miller, Bryant D.
AU - Di Stefano, Luciano H.
AU - Ruiz, Francesc Xavier
AU - Hancock, Matthew
AU - Işik, Esin
AU - Mendez-Dorantes, Carlos
AU - Walpole, Thomas
AU - Nichols, Charles
AU - Wan, Paul
AU - Riento, Kirsi
AU - Halls-Kass, Rowan
AU - Augustin, Martin
AU - Lammens, Alfred
AU - Jestel, Anja
AU - Upla, Paula
AU - Xibinaku, Kera
AU - Congreve, Samantha
AU - Hennink, Maximiliaan
AU - Rogala, Kacper B.
AU - Schneider, Anna M.
AU - Fairman, Jennifer E.
AU - Christensen, Shawn M.
AU - Desrosiers, Brian
AU - Bisacchi, Gregory S.
AU - Saunders, Oliver L.
AU - Hafeez, Nafeeza
AU - Miao, Wenyan
AU - Kapeller, Rosana
AU - Zaller, Dennis M.
AU - Sali, Andrej
AU - Weichenrieder, Oliver
AU - Burns, Kathleen H.
AU - Götte, Matthias
AU - Rout, Michael P.
AU - Arnold, Eddy
AU - Greenbaum, Benjamin D.
AU - Romero, Donna L.
AU - LaCava, John
AU - Taylor, Martin S.
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2024/2/1
Y1 - 2024/2/1
N2 - The LINE-1 (L1) retrotransposon is an ancient genetic parasite that has written around one-third of the human genome through a ‘copy and paste’ mechanism catalysed by its multifunctional enzyme, open reading frame 2 protein (ORF2p)1. ORF2p reverse transcriptase (RT) and endonuclease activities have been implicated in the pathophysiology of cancer2,3, autoimmunity4,5 and ageing6,7, making ORF2p a potential therapeutic target. However, a lack of structural and mechanistic knowledge has hampered efforts to rationally exploit it. We report structures of the human ORF2p ‘core’ (residues 238–1061, including the RT domain) by X-ray crystallography and cryo-electron microscopy in several conformational states. Our analyses identified two previously undescribed folded domains, extensive contacts to RNA templates and associated adaptations that contribute to unique aspects of the L1 replication cycle. Computed integrative structural models of full-length ORF2p show a dynamic closed-ring conformation that appears to open during retrotransposition. We characterize ORF2p RT inhibition and reveal its underlying structural basis. Imaging and biochemistry show that non-canonical cytosolic ORF2p RT activity can produce RNA:DNA hybrids, activating innate immune signalling through cGAS/STING and resulting in interferon production6–8. In contrast to retroviral RTs, L1 RT is efficiently primed by short RNAs and hairpins, which probably explains cytosolic priming. Other biochemical activities including processivity, DNA-directed polymerization, non-templated base addition and template switching together allow us to propose a revised L1 insertion model. Finally, our evolutionary analysis demonstrates structural conservation between ORF2p and other RNA- and DNA-dependent polymerases. We therefore provide key mechanistic insights into L1 polymerization and insertion, shed light on the evolutionary history of L1 and enable rational drug development targeting L1.
AB - The LINE-1 (L1) retrotransposon is an ancient genetic parasite that has written around one-third of the human genome through a ‘copy and paste’ mechanism catalysed by its multifunctional enzyme, open reading frame 2 protein (ORF2p)1. ORF2p reverse transcriptase (RT) and endonuclease activities have been implicated in the pathophysiology of cancer2,3, autoimmunity4,5 and ageing6,7, making ORF2p a potential therapeutic target. However, a lack of structural and mechanistic knowledge has hampered efforts to rationally exploit it. We report structures of the human ORF2p ‘core’ (residues 238–1061, including the RT domain) by X-ray crystallography and cryo-electron microscopy in several conformational states. Our analyses identified two previously undescribed folded domains, extensive contacts to RNA templates and associated adaptations that contribute to unique aspects of the L1 replication cycle. Computed integrative structural models of full-length ORF2p show a dynamic closed-ring conformation that appears to open during retrotransposition. We characterize ORF2p RT inhibition and reveal its underlying structural basis. Imaging and biochemistry show that non-canonical cytosolic ORF2p RT activity can produce RNA:DNA hybrids, activating innate immune signalling through cGAS/STING and resulting in interferon production6–8. In contrast to retroviral RTs, L1 RT is efficiently primed by short RNAs and hairpins, which probably explains cytosolic priming. Other biochemical activities including processivity, DNA-directed polymerization, non-templated base addition and template switching together allow us to propose a revised L1 insertion model. Finally, our evolutionary analysis demonstrates structural conservation between ORF2p and other RNA- and DNA-dependent polymerases. We therefore provide key mechanistic insights into L1 polymerization and insertion, shed light on the evolutionary history of L1 and enable rational drug development targeting L1.
UR - http://www.scopus.com/inward/record.url?scp=85183058176&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183058176&partnerID=8YFLogxK
U2 - 10.1038/s41586-023-06947-z
DO - 10.1038/s41586-023-06947-z
M3 - Article
C2 - 38096902
AN - SCOPUS:85183058176
SN - 0028-0836
VL - 626
SP - 194
EP - 206
JO - Nature
JF - Nature
IS - 7997
ER -